Report Highlights
The global market for selected health self-monitoring technologies reached $1.1 billion and nearly $3.2 billion in 2013 and 2014, respectively. This market is forecast to grow at a compound annual growth rate (CAGR) of 42.9% to reach $18.8 billion in 2019.
Report Includes
- Overview the global markets and technologies for health self-monitoring.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- Identify and describe existing health self-monitoring technologies, as well as technologies that are under development.
- Analyze the major drivers and constraints that will influence the future development of the self-monitoring market.
- Project the market for major health self-monitoring technology platforms, devices, and software.
- Describe and evaluate different vendors’ business models.
- Assess the potential impact of self-monitoring on the way medicine is practiced.
Report Scope
BCC Research has published studies of several related topics, including wearable computing (IFT071A), telemedicine (HLC014E), patient monitoring (HLC038D), smart textiles (AVM050B) and healthcare IT (HLC048D). The present study complements, rather than duplicates, these studies.
For example, the wearable computing study (IFT071A) discusses the likelihood that “activity monitoring applications” for sports and fitness will expand to other health and wellness markets but does not discuss these health and wellness application in much detail. IFT071A also discusses “wearable healthcare devices and safety monitors,” but the latter are intended more for third-party (e.g., caregiver) monitoring rather than self-monitoring. The same is true of the patient monitoring technologies analyzed in HLC038D, HLC014E and AVM050B.
The present report focuses specifically on technologies that enable the individual to monitor his or her own health. Third-party monitoring technologies thus are specifically excluded, except to the extent that the individual being monitored has direct access to the data, in a form useful for self-monitoring. Apps that extract data from an individual’s EHR and format and display those data on the individual’s self-monitoring device are covered in the report, but not EHRs per se. The latter are covered in BCC Research report HLC048D.
Additional, unique topics covered in this report include:
- Self-tracking’s usability by target groups such as seniors.
- Vendor business models (e.g., many self-tracking apps are free. How are vendors going to make money in this market?).
- Structural impacts on the healthcare industry.
The study format includes these major elements:
- Executive summary.
- Overview (definitions, enabling technologies, market segmentation).
- Market environment (demographic, economic, epidemiological, legal/ regulator, healthcare industry).
- Major health self-monitoring platforms.
- Health self-monitoring hubs.
- Peripherals.
- Software.
- Company profiles.
- Patent analysis.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Related Reports
Global Markets for Telemedicine Technologies
The global telehospital/clinic and telehome market reached $16.3 billion in 2013 and $19.2 billion in 2014, and should reach about $43.4 billion in 2019 with a compound annual growth (CAGR) of 17.7% through 2019.
Biometrics: Technologies and Global Markets
The global market for biometric technologies is estimated to be $8.7 billion in 2013. In 2014, the forecasted revenues will likely reach almost $11.2 billion and $27.5 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 19.8%.
MEMS: Biosensors and Nanosensors
The global microsensor market was valued at $8.5 billion in 2012. The market is expected to grow to $9.5 billion in 2013 and $15.8 billion in 2018 for a compound annual growth rate (CAGR) of 10.7%.
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at nearly $2.8 billion in 2011, nearly $3.2 billion in 2012, and is forecast to grow to nearly $7.5 billion by 2017 after increasing at a compound annual growth rate (CAGR) of 18.7%.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More